Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

3.04USD
2:34pm GMT
Change (% chg)

$0.03 (+1.00%)
Prev Close
$3.01
Open
$3.00
Day's High
$3.04
Day's Low
$2.97
Volume
11,479
Avg. Vol
39,398
52-wk High
$4.35
52-wk Low
$1.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 0.00 -0.158
FY 2018 Sep '18 0.00 -0.127
Jun '18 0.00 -0.063
Mar '18 0.00 -0.107
Dec 0.00 -0.093
FY 2017 Sep '17 0.00 -0.122
Jun '17 0.00 -0.087
Mar '17 0.00 -0.038
Dec 0.00 -0.082
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 1 0.00 0.00 0.00 0.00
Year Ending Sep-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 1 -0.14 -0.14 -0.14 -0.11
Quarter Ending Jun-19 1 -0.14 -0.14 -0.14 -0.13
Year Ending Sep-19 1 -0.58 -0.58 -0.58 -0.47
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.73 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta 1.01 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) 7.57 10.19 5.27
Price to Tangible Book (MRQ) 7.57 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 24.62 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -38.62 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago 9.14 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 17.09 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.49 11.35
Total Debt to Equity (MRQ) 0.00 32.17 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.47 12.43
Operating Margin (TTM) -- -185.05 5.77
Operating Margin - 5 Yr. Avg. -- -126.95 8.02
Pre-Tax Margin (TTM) -- -175.75 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.74 8.31
Net Profit Margin (TTM) -- -182.47 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.14 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.51 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,655,760 820,341,642
Net Income/Employee (TTM) -1,481,687 514,151 92,858,478
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.28 6.36 10.60
Return on Assets - 5 Yr. Avg. -173.84 5.46 11.78
Return on Investment (TTM) -95.21 8.89 13.82
Return on Investment - 5 Yr. Avg. -289.36 6.77 15.32
Return on Equity (TTM) -95.21 10.00 15.25
Return on Equity - 5 Yr. Avg. -476.42 8.30 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Anavex Life Sciences Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.66 -12.77 34 99
13 Week -21.31 -25.14 36 95
26 Week -28.16 -33.62 48 98
52 Week 17.27 -0.60 99 71
YTD 6.31 -6.64 97 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.46%
# of Holders: 57
Total Shares Held: 5,841,577
3 Mo. Net Change: -2,457,607
# New Positions: 7
# Closed Positions: 8
# Increased Positions: 18
# Reduced Positions: 22
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.